What the analyst said
Barclays analyst Raimo Lenschow raised the price target on Oracle (NYSE: ORCL) to $250.00 (from $240.00) while maintaining an Overweight rating.
“We are puzzled by ORCL’s after-hour share price reaction (down meaningfully). True, cloud application and software (license plus maintenance) were slightly below consensus, but these are the parts that matter less for Oracle going forward.
What is more important is that Oracle had another large RPO beat, suggesting ongoing AI demand that outweighs supply and ongoing momentum for ORCL. The additional RPO is not driving crazy new funding needs though as BYOC (Bring-Your-Own-Chips) and prepayments are now major components of the new deals.
In other words, management got the message that the market wants to see growth but with a healthy ROIC profile. The new CFO clarified CapEx plans for next year (~$70bn net CapEx, $90-95bn reported, which includes customer prepayments of $20-25bn, which seems to be below investor expectations on a net basis) and reiterated the FY 2030 targets.
Long-term investors can now revisit the story as the growth outlook is the same or better while the return profile is likely increasing from here. At the current valuation level of ~21x CY27E P/E, we see this as very attractive. We reiterate our Overweight rating and raise our price target to $250 (from $240).”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
ORCL trades at $101. The 23 analysts who set a target in the last 3 months range from $155 to $400, with a median of $240. This $250 target is 4% above the median.
Since the note ORCL has moved −50% (from $201). 12-month window: day 163 of 365, closes on June 11, 2027.
Track record
This callOpen: ORCL has not reached $250 yet. This 12-month target is scored on June 11, 2027.
Firm track recordBarclays: 82% of its 44 targets at least a year old were reached within 12 months (#9 of 29 firms). Accuracy ranking →
Barclays on Oracle
Barclays price targets on Oracle
6 calls from February 2, 2026 to September 11, 2026. The target went from $310 to $252 (−19%). The rating stayed Buy.
- September 11, 2026Target raised from $250 (+1%)Buy$252
- June 11, 2026 This noteTarget raised from $240 (+4%)Buy$250
- June 8, 2026Kept the $240 targetBuy$240
- March 11, 2026Target raised from $230 (+4%)Buy$240
- March 9, 2026Target cut from $310 (−26%)Buy$230
- February 2, 2026Earliest call shownBuy$310





